IPP Bureau
Alkem forays into ophthalmology with launch of eye care products
By IPP Bureau - July 07, 2023
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
Croda completes acquisition of Solus Biotech
By IPP Bureau - July 06, 2023
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
Syngene to acquire multi-modal facility from Stelis Biopharma
By IPP Bureau - July 05, 2023
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
Lupin receives tentative approval from USFDA for Dolutegravir Tablets for oral suspension
By IPP Bureau - July 05, 2023
Dolutegravir Tablets for Oral Suspension (RLD Tivicay PD®) had estimated annual sales of USD 1 million in the U.S. (IQVIA MAT March 2023)
Zydus receives final approval from the USFDA for Oxcarbazepine Tablets
By IPP Bureau - July 05, 2023
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
CARE reaffirms A+ rating to IOL Chemicals and Pharmaceuticals
By IPP Bureau - July 05, 2023
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
Cipla bags sustainable companies rankings for 2022-23
By IPP Bureau - July 05, 2023
Cipla has a robust governance model focused on sustainability
Evonik showcases smart technology for dental prostheses
By IPP Bureau - July 05, 2023
PEEK brings a new quality to dental care for patients
Venus Remedies gets marketing approvals for oncology medicine from 4 key markets
By IPP Bureau - July 05, 2023
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
Merck India appoints Pratima Reddy as Country Speaker
By IPP Bureau - July 05, 2023
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
Biocon Biologics expands footprint in emerging markets
By IPP Bureau - July 05, 2023
Takes over the commercialization of Biosimilars Business from Viatris in 70+ countries
Apex laboratories introduces OVAPEX Tablets for managing PCOS & female infertility
By IPP Bureau - July 05, 2023
OVAPEX is a unique formula developed by the team of scientists and doctors at Green Milk Concepts
Healthium Medtech appoints Dr. Vivek S. Iyer as GM for Professional Education & Market Growth Strategy
By IPP Bureau - July 05, 2023
Dr. Vivek joins Healthium after a stint at Ethicon, Johnson & Johnson
Solara Active Pharma approves rights issue of Rs. 450 Cr
By IPP Bureau - July 05, 2023
The detailed terms in relation to the Rights Issue, including but not limited to the issue price, rights entitlement ratio, record date, timing and terms of payment will be determined in due course.
BDR Pharma's Nilotinib sets a new standard in the treatment of Philadelphia Chromosome-positive leukaemia
By IPP Bureau - July 05, 2023
Rare childhood cancer subtype, Ph+ ALL, is found in 3-4% of pediatric cases and 25% of adult cases
